502 related articles for article (PubMed ID: 2479244)
21. IgE, IgG1, and IgG4 antibody responses to Blomia tropicalis in atopic patients.
Pereira EA; Silva DA; Cunha-Júnior JP; Almeida KC; Alves R; Sung SJ; Taketomi EA
Allergy; 2005 Mar; 60(3):401-6. PubMed ID: 15679730
[TBL] [Abstract][Full Text] [Related]
22. Variations of histamine release in an atopic population. II. Clinical situation according to age and duration of immunotherapy.
Gamboa PM; Castillo JG; Wong E; de la Cuesta CG; Oehling A
Allergol Immunopathol (Madr); 1989; 17(6):279-83. PubMed ID: 2483969
[TBL] [Abstract][Full Text] [Related]
23. Limited IgE cross-reactivity between Dermatophagoides pteronyssinus and Glycyphagus domesticus in patients naturally exposed to both mite species.
Arias-Irigoyen J; Lombardero M; Arteaga C; Carpizo JA; Barber D
J Allergy Clin Immunol; 2007 Jul; 120(1):98-104. PubMed ID: 17412407
[TBL] [Abstract][Full Text] [Related]
24. Immunologic evaluation of 24 month course of sublingual immunotherapy.
Tari MG; Mancino M; Madonna F; Buzzoni L; Parmiani S
Allergol Immunopathol (Madr); 1994; 22(5):209-16. PubMed ID: 7840022
[TBL] [Abstract][Full Text] [Related]
25. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
[TBL] [Abstract][Full Text] [Related]
26. Effects of immunotherapy on histamine release: a study in allergy to dermatophagoides and house dust.
Trento H; Oehling A; Ona J
Allergol Immunopathol (Madr); 1982; 10(4):295-300. PubMed ID: 6184978
[TBL] [Abstract][Full Text] [Related]
27. [Conjunctival provocation test with Dermatophagoides pteronyssinus in the diagnosis of allergic conjunctivitis from house mites].
Bertel F; Mortemousque B; Sicard H; André C
J Fr Ophtalmol; 2001 Jun; 24(6):581-9. PubMed ID: 11460053
[TBL] [Abstract][Full Text] [Related]
28. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy.
Tonnel AB; Scherpereel A; Douay B; Mellin B; Leprince D; Goldstein N; Delecluse P; Andre C
Allergy; 2004 May; 59(5):491-7. PubMed ID: 15080829
[TBL] [Abstract][Full Text] [Related]
29. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
30. [Changes in histamine liberation induced by house dust mites after the administration of procaterol].
Rubio N; Lizaso M; Mateo J; Elorza FL
Allergol Immunopathol (Madr); 1986; 14(2):127-32. PubMed ID: 2424293
[TBL] [Abstract][Full Text] [Related]
31. Skin cross-reactivity between Dermatophagoides pteronyssinus and storage mites in atopic children.
Sánchez Palacios A; García Marrero JA; Limiñana Cañal JM; Schaman F; Alonso Bordón J; Gutiérrez Pérez AT
J Investig Allergol Clin Immunol; 1991 Jun; 1(3):179-84. PubMed ID: 1669575
[TBL] [Abstract][Full Text] [Related]
32. [Rush immunotherapy of perennial allergic rhinitis].
Ito K
Arerugi; 1989 Nov; 38(11):1246-54. PubMed ID: 2627159
[TBL] [Abstract][Full Text] [Related]
33. [Specific IgG and IgE antibodies in house dust mite asthmatic patients and control probands].
Sarvan M; Noyan O; Debelić M
Pneumologie; 1990 Feb; 44 Suppl 1():375-7. PubMed ID: 2367421
[TBL] [Abstract][Full Text] [Related]
34. Lack of specific IgE against house-dust and Dermatophagoides pteronyssinus in aspirin-sensitive asthmatics with positive skin and inhalation test.
Swatko A; Grzelewska-Rzymowska I; Rozniecki J; Szmidt M
Allergol Immunopathol (Madr); 1982; 10(4):277-82. PubMed ID: 7180793
[TBL] [Abstract][Full Text] [Related]
35. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
[TBL] [Abstract][Full Text] [Related]
36. IgG, IgA, IgM and IgE serum levels in asthmatic patients sensitive to house dust and mite allergens after two-year specific immunotherapy.
Szymański W; Chyrek-Borowska S; Obrzut D
Arch Immunol Ther Exp (Warsz); 1984; 32(4):381-7. PubMed ID: 6534314
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of rapid injection immunotherapy by antigen specific IgE and IgG4 antibodies].
Satoh Y; Sugimoto K; Kuroki H; Fuzimoto N; Suzuki H
Arerugi; 1989 Mar; 38(3):246-53. PubMed ID: 2751431
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of efficacy and safety of intrabronchial specific immunotherapy with allergy medication against allergies to house mites among patients with bronchial asthma].
Zietkowski Z
Pol Merkur Lekarski; 1999 May; 6(35):239-41. PubMed ID: 10437390
[TBL] [Abstract][Full Text] [Related]
39. Variations in antigen-specific histamine release related with immunotherapeutic treatment.
Castillo JG; Gamboa PM; Oehling A; Wong E; de la Cuesta CG
Allergol Immunopathol (Madr); 1989; 17(3):149-53. PubMed ID: 2479245
[TBL] [Abstract][Full Text] [Related]
40. Reliability of histamine release test in dust mite allergy: influence of the degree of sensitization.
Resano A; Prieto I; Sanz ML; Oehling A
J Investig Allergol Clin Immunol; 1995; 5(5):289-93. PubMed ID: 8574438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
